Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Diaconu

Showing results (141-150 of 336) with videos related to

Pageof 34
Sort By:
Blood|March 2, 2012
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomesChristian Pecquet, Carmen C Diaconu, Judith Staerk, et al.
Journal of Cellular and Molecular Medicine|November 21, 2013
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitorsMeng Ling Choong, Christian Pecquet, Vishal Pendharkar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 17, 2010
Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patientsMaria Grigoroiu-Serbanescu, Stefan Herms, Carmen C Diaconu, et al.
Frontiers in Oncology|April 25, 2020
Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic LeukemiaAndra Marcu, Andrei Colita, Letitia Elena Radu, et al.
Blood|November 1, 2018
Cooccurring <i>JAK2</i> V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasmsCristina Mambet, Olga Babosova, Jean-Philippe Defour, et al.
International Journal of Molecular Sciences|May 27, 2026
Critical Role of Molecular-Based Stratification in Low-Risk Myelodysplastic Syndrome with Direct Progression to Acute Myeloid Leukemia: A Case ReportStejara Nicoleta Mihai, Denisa Dragu, Cristina Mambet, et al.
Frontiers in Oncology|October 16, 2023
Leukemic conversion involving <i>RAS</i> mutations of type 1 <i>CALR</i>-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case reportPetruta Gurban, Cristina Mambet, Anca Botezatu, et al.
Journal of Cellular and Molecular Medicine|January 19, 2022
Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19Mihaela Chivu-Economescu, Coralia Bleotu, Camelia Grancea, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 31, 2009
Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samplesMaria Grigoroiu-Serbanescu, Stefan Herms, Thomas W Mühleisen, et al.
Biomedicines|July 27, 2022
Assessment of the Humoral Immune Response Following COVID-19 Vaccination in Healthcare Workers: A One Year Longitudinal StudyMihaela Chivu-Economescu, Teodora Vremera, Simona Maria Ruta, et al.
Pageof 34

Showing results (141-150 of 336) with videos related to

Sort By:
Pageof 34
Blood|March 2, 2012
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomesChristian Pecquet, Carmen C Diaconu, Judith Staerk, et al.
Journal of Cellular and Molecular Medicine|November 21, 2013
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitorsMeng Ling Choong, Christian Pecquet, Vishal Pendharkar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 17, 2010
Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patientsMaria Grigoroiu-Serbanescu, Stefan Herms, Carmen C Diaconu, et al.
Frontiers in Oncology|April 25, 2020
Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic LeukemiaAndra Marcu, Andrei Colita, Letitia Elena Radu, et al.
Blood|November 1, 2018
Cooccurring <i>JAK2</i> V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasmsCristina Mambet, Olga Babosova, Jean-Philippe Defour, et al.
International Journal of Molecular Sciences|May 27, 2026
Critical Role of Molecular-Based Stratification in Low-Risk Myelodysplastic Syndrome with Direct Progression to Acute Myeloid Leukemia: A Case ReportStejara Nicoleta Mihai, Denisa Dragu, Cristina Mambet, et al.
Frontiers in Oncology|October 16, 2023
Leukemic conversion involving <i>RAS</i> mutations of type 1 <i>CALR</i>-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case reportPetruta Gurban, Cristina Mambet, Anca Botezatu, et al.
Journal of Cellular and Molecular Medicine|January 19, 2022
Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19Mihaela Chivu-Economescu, Coralia Bleotu, Camelia Grancea, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 31, 2009
Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samplesMaria Grigoroiu-Serbanescu, Stefan Herms, Thomas W Mühleisen, et al.
Biomedicines|July 27, 2022
Assessment of the Humoral Immune Response Following COVID-19 Vaccination in Healthcare Workers: A One Year Longitudinal StudyMihaela Chivu-Economescu, Teodora Vremera, Simona Maria Ruta, et al.
Pageof 34